Key result
Fluctuations in anti-Ro/SS-A and anti-La/SS-B autoantibody levels were unrelated to disease activity or the occurrence of congenital heart block over an 80-month period.
Why the study?
Can frequent measurement of anti-Ro/SS-A and anti-La/SS-B levels predict the occurrence of congenital heart block in a patient with systemic lupus erythematosus?
Case Report (n=1)
Can frequent measurement of anti-Ro/SS-A and anti-La/SS-B levels predict the occurrence of congenital heart block in a patient with systemic lupus erythematosus?
Frequent measurement of anti-Ro/SS-A and anti-La/SS-B levels cannot predict the occurrence of congenital heart block in patients with systemic lupus erythematosus.
Answers are grounded in this paper and cite their sources.
Serial anti-Ro/La monitoring may not inform congenital heart block risk; leaves open need for prospective validation of other predictors.
OBJECTIVE: To analyze the anti-Ro/SS-A and anti-La/SS-B autoantibody responses, both quantitatively and qualitatively, in relation to the occurrence of congenital heart block (CHB) and disease activity in a patient with systemic lupus erythematosus. METHODS: The patient's course was carefully documented for a period of 80 months. Specific enzyme-linked immunosorbent assays, a HeLa cell immunoblotting test, and an RNA precipitation assay were used to determine autoantibody levels and fine specificities. RESULTS: Anti-Ro/SS-A and anti-La/SS-B antibody did not disappear. Levels of anti-Ro/SS-A appeared to fluctuate more frequently than levels of anti-La/SS-B. Fluctuations were unrelated to disease activity or immunosuppressive treatment. There was no characteristic relationship between levels of these antibodies and the occurrence of CHB. CONCLUSION: The occurrence of CHB cannot be predicted by frequent measurement of anti-Ro/SS-A and anti-La/SS-B levels. The immunoregulatory control of anti-Ro/SS-A and anti-La/SS-B antibodies differs from that of anti-DNA and anti-tetanus toxoid antibodies.
No takes yet. Share an insight, caveat, or question.
Derksen et al. (1992) conducted a case report in Systemic lupus erythematosus (n=1). Anti-Ro/SS-A and anti-La/SS-B autoantibody levels was evaluated on Occurrence of congenital heart block and disease activity. Fluctuations in anti-Ro/SS-A and anti-La/SS-B autoantibody levels were unrelated to disease activity or the occurrence of congenital heart block over an 80-month period.
Synapse has enriched 10 related papers. Consider them for comparative context: